Brii Biosciences Limited
BRIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$512 | -$184 | -$490 | -$4,191 |
| Dep. & Amort. | $9 | $16 | $17 | $17 |
| Deferred Tax | $0 | $0 | $0 | -$45 |
| Stock-Based Comp. | $16 | $64 | $78 | $79 |
| Change in WC | -$50 | -$121 | -$77 | -$334 |
| Other Non-Cash | $165 | -$369 | -$24 | $3,594 |
| Operating Cash Flow | -$373 | -$594 | -$496 | -$879 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | $0 | -$139 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $2 |
| Inv. Purchases | -$1,943 | -$3,487 | -$2,102 | -$500 |
| Inv. Sales/Matur. | $2,848 | $3,268 | $775 | $20 |
| Other Inv. Act. | -$6 | $115 | $33 | $3 |
| Investing Cash Flow | $895 | -$104 | -$1,433 | -$476 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7 | -$10 | -$9 | -$10 |
| Stock Issued | $0 | $0 | $7 | $2,325 |
| Stock Repurch. | -$0 | -$1 | -$1 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$0 | -$1 | $915 |
| Financing Cash Flow | -$9 | -$11 | -$3 | $3,230 |
| Forex Effect | $1 | $8 | $268 | -$55 |
| Net Chg. in Cash | $514 | -$701 | -$1,665 | $1,820 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $490 | $1,191 | $2,855 | $1,035 |
| End Cash | $1,003 | $490 | $1,191 | $2,855 |
| Free Cash Flow | -$376 | -$644 | -$636 | -$880 |